日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and safety of dapagliflozin in patients hospitalized with COVID-19 with and without type 2 diabetes: a prespecified analysis of the DARE-19 randomized trial

达格列净治疗伴或不伴2型糖尿病的COVID-19住院患者的疗效和安全性:DARE-19随机试验的预设分析

Abdel Jawad, Mohammad; Furtado, Remo H M; Esterline, Russell; Oscarsson, Jan; Gasparyan, Samvel B; Koch, Gary G; Martinez, Felipe; Mukhtar, Omar; Verma, Subodh; Langkilde, Anna Maria; Ambery, Philip; Patel, Shachi; Gosch, Kensey; Windsor, Sheryl L; Soares, Ronaldo V P; Moia, Diogo D F; Aboudara, Matthew; Javaheri, Ali; Saraiva, J F Kerr; Maia, Lilia Nigro; Berwanger, Otavio; Sauer, Andrew J; Kosiborod, Mikhail N

Use of eGFR Slope Thresholds as End Point Components in a Kidney Disease Progression Hierarchical Composite End Point

在肾脏疾病进展分层复合终点中使用 eGFR 斜率阈值作为终点组成部分

Jongs, Niels; Gasparyan, Samvel B; Frison, Lars; Schloemer, Patrick; Brinker, Meike; Little, Dustin J; Heerspink, Hiddo J L

Survival Odds to Minimize Risk Heterogeneity Bias in Heart Failure Trials: Application to Dapagliflozin

利用生存优势比来最小化心力衰竭试验中的风险异质性偏倚:以达格列净为例

Myte, Robin; Mattsson, Andrea; Poole, Matt; Little, Dustin J; Nyström, Per; Henderson, Alasdair; Claggett, Brian L; Gasparyan, Samvel B; Solomon, Scott D; McMurray, John J V

A hierarchical kidney outcome using win statistics in patients with heart failure from the DAPA-HF and DELIVER trials

基于 DAPA-HF 和 DELIVER 试验中心力衰竭患者的 Win 统计量,对肾脏结局进行分层分析

Kondo, Toru; Jhund, Pardeep S; Gasparyan, Samvel B; Yang, Mingming; Claggett, Brian L; McCausland, Finnian R; Tolomeo, Paolo; Vadagunathan, Muthiah; Heerspink, Hiddo J L; Solomon, Scott D; McMurray, John J V

Effect of Dapagliflozin on Total Heart Failure Events in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the DELIVER Trial

达格列净对射血分数轻度降低或保留的心力衰竭患者总心力衰竭事件的影响:DELIVER试验的预设分析

Jhund, Pardeep S; Claggett, Brian L; Talebi, Atefeh; Butt, Jawad H; Gasparyan, Samvel B; Wei, Lee-Jen; McCaw, Zachary R; Wilderäng, Ulrica; Bengtsson, Olof; Desai, Akshay S; Petersson, Magnus; Langkilde, Anna Maria; de Boer, Rudolf A; Hernandez, Adrian F; Inzucchi, Silvio E; Kosiborod, Mikhail N; Lam, Carolyn S P; Martinez, Felipe A; Shah, Sanjiv J; Vaduganathan, Muthiah; Solomon, Scott D; McMurray, John J V

Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression

肾病进展临床试验中新型分层复合终点的开发与验证

Heerspink, Hiddo J L; Jongs, Niels; Schloemer, Patrick; Little, Dustin J; Brinker, Meike; Tasto, Christoph; Karpefors, Martin; Wheeler, David C; Bakris, George; Perkovic, Vlado; Nkulikiyinka, Richard; Rossert, Jerome; Gasparyan, Samvel B

Validity and Utility of a Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression: A Review

肾病进展临床试验中分层复合终点的有效性和实用性:一项综述

Little, Dustin J; Gasparyan, Samvel B; Schloemer, Patrick; Jongs, Niels; Brinker, Meike; Karpefors, Martin; Tasto, Christoph; Rethemeier, Nicole; Frison, Lars; Nkulikiyinka, Richard; Rossert, Jerome; Heerspink, Hiddo J L

Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER

达格列净治疗射血分数范围广泛的心力衰竭患者:DAPA-HF 和 DELIVER 研究的患者水平汇总荟萃分析

Jhund, Pardeep S; Kondo, Toru; Butt, Jawad H; Docherty, Kieran F; Claggett, Brian L; Desai, Akshay S; Vaduganathan, Muthiah; Gasparyan, Samvel B; Bengtsson, Olof; Lindholm, Daniel; Petersson, Magnus; Langkilde, Anna Maria; de Boer, Rudolf A; DeMets, David; Hernandez, Adrian F; Inzucchi, Silvio E; Kosiborod, Mikhail N; Køber, Lars; Lam, Carolyn S P; Martinez, Felipe A; Sabatine, Marc S; Shah, Sanjiv J; Solomon, Scott D; McMurray, John J V

Dapagliflozin in patients with COVID-19: mind the kidneys - Authors' reply

达格列净用于新冠肺炎患者:注意肾脏——作者回复

Kosiborod, Mikhail N; Esterline, Russell; Oscarsson, Jan; Gasparyan, Samvel B; Furtado, Remo H M; Verma, Subodh; Berwanger, Otavio

Dapagliflozin and Kidney Outcomes in Hospitalized Patients with COVID-19 Infection: An Analysis of the DARE-19 Randomized Controlled Trial

达格列净对新冠肺炎住院患者肾脏结局的影响:DARE-19随机对照试验分析

Heerspink, Hiddo J L; Furtado, Remo H M; Berwanger, Otavio; Koch, Gary G; Martinez, Felipe; Mukhtar, Omar; Verma, Subodh; Gasparyan, Samvel B; Tang, Fengming; Windsor, Sheryl L; de Souza-Dantas, Vicente Cés; Del Sueldo, Mildren; Frankel, Robert; Javaheri, Ali; Maldonado, Rafael A; Morse, Caryn; Mota-Gomes, Marco; Shemin, Douglas; Silva, Osvaldo Lourenço Jr; Tognon, Alexandre Pereira; Twahirwa, Marcel; Buenconsejo, Joan; Esterline, Russell; Oscarsson, Jan; Ambery, Philip; Langkilde, Anna Maria; Kosiborod, Mikhail N